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Background: Reports on the concomitant impact of HIV infec-
tion and long term cross-reactive HAART on the genetic variability
and molecular evolution of HBV over time are limited. This
longitudinal study retrospectively investigated themolecular char-
acteristics of chronicHBV inHIVco-infectedpatients on lamivudine
(3TC)-based HAART, over the course of a 5 year period.
Methods & Materials: Four HIV co-infected patients consecu-
tively recruited and followed-up from 2004 to 2008 were screened
for complete hepatitis B seromarkers and viral loads determined.
HBV full length genome isolates were ampliﬁed and directly
sequenced from serial samples. Evolutionary analyses were then
conducted andprediction of phenotypic drug resistance and escape
mutations carried out.
Results: All patients exhibited persistent chronic HBV infection
at baseline, prior to 3TC-basedHAART initiation andover the course
of follow-up. Based on phylogenetic clustering, it could be deter-
mined that all but one patientwere infectedwithHBV subgenotype
A1. The greatest evolutionary distance determined was 0.008 (∼25
base substitutions within the 3.2 Kb genome) after 5 years of per-
sistent chronic HBV infection with exposure to 3TC-based HAART.
Positive selection pressure, based on dS/dN ratios <0.05, was evi-
dent within structural genes (pre-S/S and Pre-C/C). It was noted
that the pol ORF in all study patients’ isolates was relatively vari-
able prior to HAART initiation at baseline and during the course of
follow-up.
Conclusion: Overall, HBV exhibited limited evolutionary rates
even after 5 years,which could be attributed to theminimal genetic
diversity observed. The impact of current TDF-based HAART regi-
mens on the molecular evolution of HBV in HIV co-infected South
African patients should be investigated.
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Elevation in liver enzymes are associated with
increased IL-2 and may predict severe outcomes
of dengue virus infection in a Sri Lankan cohort
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Background: A synergistic effect of host genetic factors, host
immunity and the virulence of dengue viruses (DENV) contribute
to the pathogenesis of DENV infections. In severe DENV infections,
the hepatic transaminase AST level increasesmore than the hepatic
transaminase ALT.
IL-2 and TNF-  are both elevated in DENV infection as a part of
the body’s early response to infection. The objective was to assess
the correlation between changes in IL-2 and TNF-  levels with
changes in liver enzymes in dengue patients with varying clinical
severity.
Methods & Materials: A total of 67 DENV infected patients
(DF=24 andDHF=43) either conﬁrmedby ELISA or RT-PCR from July
2011 to February 2012 from General Hospital Kandy were selected
for the IL-2 and TNF- evaluation using a single analyte ELISArray
(Qiagen, Germany). Clinical, haematological parameters and hep-
atic transaminases (AST and ALT)were recorded on admission. Five
mL of blood was collected from DENV suspected patients on fever
days 5 or less (onset of fever was considered as day 1).
Results: Of the patients, 47.76% (n=32) showed AST: ALT >2.
AST: ALT mean ±SD among DF was 1.64±0.74 U/L while it was
3.18± 4.50 U/L for DHF/DSS patients.
No signiﬁcant correlationwasnoted betweenAST: ALT andTNF-
 and also with IL-2. A signiﬁcant positive linear correlation was
observed between AST and IL-2 levels (r= 0.31 p = 0.01) and also
between ALT and IL-2 levels (r= 0.27 p = 0.02). No signiﬁcant cor-
relation was noted between AST and TNF- and ALT and IL-2.
Conclusion: Almost half of our study population showed AST:
ALT>2 indicating acute changes in liver function and the potential
for liver derangement due to DENV infection. There was a statis-
tically signiﬁcant positive correlation between the IL-2 with AST
and ALT levels, although no correlation was noted between AST
and ALT with TNF -. The positive correlations between elevations
of AST and ALT with IL-2, and the association of higher levels of
these factors inDHF/DSS comparedwithDF suggest that thesemea-
surements may be useful predictors for the progression of DENV
infection to severe DF/DHF.
http://dx.doi.org/10.1016/j.ijid.2016.02.967
